Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
FDF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Bay 946
2. Bay-946
3. Elmiron
4. Fibrocid
5. Hemoclar
6. Hoe 946
7. Hoe Bay 946
8. Hoe-946
9. Hoe-bay 946
10. Hoe-bay-946
11. Pentosan Polysulfate Sodium
12. Pentosan Polysulphate Sodium
13. Pentosan Sulfuric Polyester
14. Pentosane Sulfuric Polyester
15. Polyester, Pentosan Sulfuric
16. Polyester, Pentosane Sulfuric
17. Polypentose Sulfate
18. Polysulfate Sodium, Pentosan
19. Polysulfate, Pentosan
20. Polysulfated Xylan
21. Polysulphate Sodium, Pentosan
22. Pz 68
23. Pz-68
24. Pz68
25. Sodium, Pentosan Polysulfate
26. Sodium, Pentosan Polysulphate
27. Sp 54
28. Sp 54, Tavan
29. Sp-54
30. Sp54
31. Sp54, Xylan
32. Sulfate, Polypentose
33. Sulfate, Xylan
34. Sulfuric Polyester, Pentosan
35. Sulfuric Polyester, Pentosane
36. Tavan Sp 54
37. Xylan Sp54
38. Xylan Sulfate
39. Xylan, Polysulfated
1. 37300-21-3
2. Pentosan Sulfuric Polyester
3. Polypentose Sulfate
4. [(2r,3r,4s,5r)-2-hydroxy-5-[(2s,3r,4s,5r)-5-hydroxy-3,4-disulfooxyoxan-2-yl]oxy-3-sulfooxyoxan-4-yl] Hydrogen Sulfate
5. Xylan, Hydrogen Sulfate
6. Unii-f59p8b75r4
7. Schembl157354
8. Chembl4073796
9. Chebi:184555
10. F59p8b75r4
11. Db00686
12. Q7165276
13. [(2r,3r,4s,5r)-2-hydroxy-5-[(2s,3r,4s,5r)-5-hydroxy-3,4-disulooxyoxan-2-yl]oxy-3-sulooxyoxan-4-yl] Hydrogen Sulate
14. [(2r,3r,4s,5r)-2-hydroxy-5-{[(2s,3r,4s,5r)-5-hydroxy-3,4-bis(sulfooxy)oxan-2-yl]oxy}-4-(sulfooxy)oxan-3-yl]oxidanesulfonic Acid
15. [(2s,3r,4s,5r)-5-hydroxy-2-{[(3r,4s,5r,6r)-6-hydroxy-4,5-bis(sulfooxy)oxan-3-yl]oxy}-4-(sulfooxy)oxan-3-yl]oxidanesulfonic Acid
16. 11096-31-4
Molecular Weight | 602.5 g/mol |
---|---|
Molecular Formula | C10H18O21S4 |
XLogP3 | -5.6 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 21 |
Rotatable Bond Count | 10 |
Exact Mass | 601.92234227 g/mol |
Monoisotopic Mass | 601.92234227 g/mol |
Topological Polar Surface Area | 356 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 1140 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Elmiron |
PubMed Health | Pentosan Polysulfate Sodium (By mouth) |
Drug Classes | Cystitis Agent, Urinary Stone Agent |
Drug Label | Pentosan polysulfate sodium is a semi-synthetically produced heparin-like macromolecular carbohydrate derivative, which chemically and structurally resembles glycosaminoglycans. It is a white odorless powder, slightly hygroscopic and soluble in water... |
Active Ingredient | Pentosan polysulfate sodium |
Dosage Form | Capsule |
Route | Oral |
Strength | 100mg |
Market Status | Prescription |
Company | Janssen Pharms |
2 of 2 | |
---|---|
Drug Name | Elmiron |
PubMed Health | Pentosan Polysulfate Sodium (By mouth) |
Drug Classes | Cystitis Agent, Urinary Stone Agent |
Drug Label | Pentosan polysulfate sodium is a semi-synthetically produced heparin-like macromolecular carbohydrate derivative, which chemically and structurally resembles glycosaminoglycans. It is a white odorless powder, slightly hygroscopic and soluble in water... |
Active Ingredient | Pentosan polysulfate sodium |
Dosage Form | Capsule |
Route | Oral |
Strength | 100mg |
Market Status | Prescription |
Company | Janssen Pharms |
For the relief of bladder pain or discomfort associated with interstitial cystitis.
FDA Label
Pentosan polysulfate sodium is a low molecular weight heparin-like compound. It has anticoagulant and fibrinolytic effects.
Anticoagulants
Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)
Absorption
Slow
4.8 hours
Pentosan polysulfate is a polymer of xylose hydrogen sulfate and contains two sulfate groups per carbohydrate monomer. It binds Fibroblast growth factors (FGFs) as well as other heparin-binding growth factors. It has been shown to interact also with the heparin-binding site of FGFR-1. It inhibits the growth of SW13 adrenocortical cells transfected with FGF-4 and tumorigenicity of MCF-7 breast carcinoma cells transfected with FGF-1 or FGF-4.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31045
Submission : 2016-10-17
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25011
Submission : 2011-05-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22582
Submission : 2009-02-20
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-11-12
Pay. Date : 2019-08-28
DMF Number : 34095
Submission : 2019-09-13
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21248
Submission : 2008-01-10
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4439
Submission : 1981-04-14
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-06-14
Pay. Date : 2023-05-24
DMF Number : 38294
Submission : 2023-05-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8811
Submission : 1990-09-18
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25827
Submission : 2012-02-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31208
Submission : 2017-01-16
Status : Active
Type : II
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2022-06-15
Registration Number : 20220615-209-J-1314
Manufacturer Name : Aragen Life Sciences Limited
Manufacturer Address : Manufacturing Unit-I, Plot No. 28A, IDA, Nacharam Village, Uppal Mandal, Medchal - Ma...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?